Open AccessCost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
Author(s) -
Rive,
Bart Hoogveldt,
Johan L. Severens,
Khaled Maman,
C Guilhaume
Publication year - 2011
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s19239
Subject(s) - medicine , memantine , disease , alzheimer's disease , intensive care medicine , dementia , pharmacology
The purpose of this study was to estimate the cost-effectiveness of memantine relative to standard care in patients with moderate-to-severe Alzheimer's disease in the Netherlands.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom